SCHEDULE 13G/A
Statement of Beneficial Ownership
Erasca, Inc. Filed Acc 0000935836-25-000678
Stakes reported in this filing
| Reporting person | Shares | Of the class |
|---|---|---|
| Logos Global Management LP | 13,600,000 | 4.8% |
| Logos Global Management GP LLC | 13,600,000 | 4.8% |
| Arsani William | 13,600,000 | 4.8% |
Members of a group can each report the same shares, so these rows overlap and don't add up.
Stake history · largest stake in each 13D and 13G
- 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Investment Management, Inc. 4.9%
- 2026-11-16 SCHEDULE 13G/A · RTW Investments, LP 6.4%
- 2026-08-14 SCHEDULE 13G/A · Jonathan E. Lim 10.4%
- 2026-05-15 SCHEDULE 13G/A · T. Rowe Price Investment Management, Inc. 6.8%
- 2026-05-15 SCHEDULE 13G/A · Venrock Healthcare Capital Partners III, L.P. 5.3%
- 2026-05-15 SCHEDULE 13G · RTW Investments, LP 5.2%
- 2026-05-15 SCHEDULE 13G/A · Paradigm BioCapital Advisors LP 3.3%
- 2026-05-12 SCHEDULE 13G/A · Suvretta Capital Management, LLC 1.1%
- 2026-02-17 SCHEDULE 13G/A · T. Rowe Price Investment Management, Inc. 5.7%
- 2026-01-14 SCHEDULE 13G · Paradigm BioCapital Advisors LP 5.3%
- 2025-11-14 SCHEDULE 13G/A · Logos Global Management LP 4.8%
- 2025-08-14 SCHEDULE 13G/A · T. Rowe Price Investment Management, Inc. 7.2%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…